People · Operator
Named in public records as an officer, director or promoter · active 2016–2023 · Other Technology, Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Duolingo, Inc. | — | Other Technology | Series B | $115.0M | $942.0M | 2020 |
| Amarillo Biosciences Inc | — | Biotechnology | Series B | $21.8M | $565.6M | 2016 |
| Newretirement, Inc. | — | Other | Series A | $10.4M | $63.8M | 2023 |
STEPHEN CHEN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside STEPHEN CHEN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Harry Weller | 1 | 21 |
| Brad Burnham | 1 | 9 |
| Andrew Moore | 1 | 5 |
| Bing Gordon | 1 | 5 |
| Steve Reale | 1 | 4 |
| Laela Sturdy | 1 | 4 |
| Timothy Chen | 1 | 3 |
| Amy Bohutinsky | 1 | 2 |
| Jim Shelton | 1 | 2 |
| Matt Skaruppa | 1 | 2 |
| Sara Clemens | 1 | 2 |
| Severin Hacker | 1 | 1 |
| Luis Von Ahn | 1 | 1 |
| YASUSHI CHIKAGAMI | 1 | 1 |
| PAUL TIBBITS | 1 | 1 |
| BERNARD COHEN | 1 | 1 |
| DANIEL FISHER | 1 | 1 |
| Chun-Hsien Tsai | 1 | 1 |
| NICHOLAS MOREN | 1 | 1 |
| EDWARD L MORRIS | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.